(1)
Kim, Y.; Shin, D. CLINICAL RESULTS OF LONG-TERM LOBEGLITAZONE ADD-ON THERAPY IN TYPE 2 DIABETES. J ASEAN Fed Endocr Soc 2023, 38, 71-72.